Tuesday - September 16, 2025

Category Archives: Pharmaceuticals & Biotech

Global Coronary Angiography Devices Market to Reach USD 21.59 Billion by 2032, Driven by Rising Cardiovascular Disease Burden and Technological Advancements, Says DelveInsight

Global Coronary Angiography Devices Market The Global Coronary Angiography Devices Market is poised for robust expansion, projected to grow from USD 12,586.91 million in 2024 to USD 21,590.61 million by 2032, reflecting a sustained CAGR of 7.03% between 2025 and … Continue reading →

Global Heart Pump Devices Market to Reach USD 9.7 Billion by 2032, Driven by Rising Cardiovascular Burden and Technological Breakthroughs, says DelveInsight

Global Heart Pump Devices Market The global heart pump devices market is poised for transformative growth, projected to increase from USD 3,143.72 million in 2024 to USD 9,748.65 million by 2032, reflecting strong and sustained expansion. The market is expected … Continue reading →

Global Minimally Invasive Surgical Devices Market Poised to Reach USD 53.26 Billion by 2032, Driven by Rising Chronic Diseases and Technological Advancements

Minimally Invasive Surgical Devices Market The global minimally invasive surgical devices market is growing at a CAGR of 7.13% during the forecast period from 2025 to 2032. The global minimally invasive surgical (MIS) devices market is set to experience strong … Continue reading →

Chronic Kidney Disease Clinical Trials Assessment 2025: Competitive Landscape, FDA Approvals, Therapies, Emerging Drugs, Mechanism of Action, Route of Administration by DelveInsight

Chronic Kidney Disease Clinical Trials Chronic Kidney Disease Companies such as AstraZeneca, Eli Lilly and Company, Shandong Suncadia Medicine, Boehringer Ingelheim, AdAlta, Alebund Pharmaceuticals, SCOHIA PHARMA, DiaMedica Therapeutics, Roche, MC2 Therapeutics, Allena Pharmaceuticals, Regulus Therapeutics, UnicoCell Biomed, Regeneron Pharmaceuticals and … Continue reading →

Knee Osteoarthritis Pipeline Analysis 2025: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight

Knee Osteoarthritis Pipeline As per DelveInsight’s assessment, globally, Knee Osteoarthritis pipeline constitutes 50+ key companies continuously working towards developing 60+ Knee Osteoarthritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments. “Knee Osteoarthritis Pipeline … Continue reading →

Chronic Obstructive Pulmonary Disease Pipeline Outlook Report 2025: Emerging Therapies and Clinical Developments by DelveInsight

DelveInsight’s “Chronic Obstructive Pulmonary Disease Pipeline Insight 2025” report provides comprehensive insights about 65+ companies and 70+ pipeline drugs in the Chronic Obstructive Pulmonary Disease pipeline landscape. It covers the Chronic Obstructive Pulmonary Disease pipeline drug profiles, including clinical and … Continue reading →

Achondroplasia Market Overview: Epidemiology, Treatment Landscape, Key Players | Ascendis Pharma, QED Therapeutics (BridgeBio), Novartis, Sanofi, RIBOMIC

Achondroplasia Market DelveInsight’s Achondroplasia Market Insights, Epidemiology, and Market Forecast 2034 report provides a detailed outlook of the current and future Achondroplasia treatment market, segmented within countries, by therapies, and by classes. Further, the market of each region is then … Continue reading →